299 related articles for article (PubMed ID: 27943633)
1. Integrated Genome and Protein Editing Swaps α-2,6 Sialylation for α-2,3 Sialic Acid on Recombinant Antibodies from CHO.
Chung CY; Wang Q; Yang S; Yin B; Zhang H; Betenbaugh M
Biotechnol J; 2017 Feb; 12(2):. PubMed ID: 27943633
[TBL] [Abstract][Full Text] [Related]
2. Chinese hamster ovary (CHO) host cell engineering to increase sialylation of recombinant therapeutic proteins by modulating sialyltransferase expression.
Lin N; Mascarenhas J; Sealover NR; George HJ; Brooks J; Kayser KJ; Gau B; Yasa I; Azadi P; Archer-Hartmann S
Biotechnol Prog; 2015; 31(2):334-46. PubMed ID: 25641927
[TBL] [Abstract][Full Text] [Related]
3. Production of α2,6-sialylated IgG1 in CHO cells.
Raymond C; Robotham A; Spearman M; Butler M; Kelly J; Durocher Y
MAbs; 2015; 7(3):571-83. PubMed ID: 25875452
[TBL] [Abstract][Full Text] [Related]
4. The interplay of protein engineering and glycoengineering to fine-tune antibody glycosylation and its impact on effector functions.
Wang Q; Wang T; Zhang R; Yang S; McFarland KS; Chung CY; Jia H; Wang LX; Cipollo JF; Betenbaugh MJ
Biotechnol Bioeng; 2022 Jan; 119(1):102-117. PubMed ID: 34647616
[TBL] [Abstract][Full Text] [Related]
5. Impact of Fc N-glycan sialylation on IgG structure.
Zhang Z; Shah B; Richardson J
MAbs; 2019; 11(8):1381-1390. PubMed ID: 31411531
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the coordinated role of ST3GAL3, ST3GAL4 and ST3GAL6 on the α2,3 sialylation linkage of mammalian glycoproteins.
Chung CY; Yin B; Wang Q; Chuang KY; Chu JH; Betenbaugh MJ
Biochem Biophys Res Commun; 2015 Jul; 463(3):211-5. PubMed ID: 25998389
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of glycosylation by stable co-expression of two sialylation-related enzymes on Chinese hamster ovary cells.
Thi Sam N; Misaki R; Ohashi T; Fujiyama K
J Biosci Bioeng; 2018 Jul; 126(1):102-110. PubMed ID: 29439861
[TBL] [Abstract][Full Text] [Related]
8. Enhanced sialylation of recombinant human erythropoietin in Chinese hamster ovary cells by combinatorial engineering of selected genes.
Son YD; Jeong YT; Park SY; Kim JH
Glycobiology; 2011 Aug; 21(8):1019-28. PubMed ID: 21436238
[TBL] [Abstract][Full Text] [Related]
9. Glycoengineering of Chinese hamster ovary cells for enhanced erythropoietin N-glycan branching and sialylation.
Yin B; Gao Y; Chung CY; Yang S; Blake E; Stuczynski MC; Tang J; Kildegaard HF; Andersen MR; Zhang H; Betenbaugh MJ
Biotechnol Bioeng; 2015 Nov; 112(11):2343-51. PubMed ID: 26154505
[TBL] [Abstract][Full Text] [Related]
10. Combinatorial genome and protein engineering yields monoclonal antibodies with hypergalactosylation from CHO cells.
Chung CY; Wang Q; Yang S; Ponce SA; Kirsch BJ; Zhang H; Betenbaugh MJ
Biotechnol Bioeng; 2017 Dec; 114(12):2848-2856. PubMed ID: 28926673
[TBL] [Abstract][Full Text] [Related]
11. Genetic engineering of CHO cells for viral resistance to minute virus of mice.
Mascarenhas JX; Korokhov N; Burger L; Kassim A; Tuter J; Miller D; Borgschulte T; George HJ; Chang A; Pintel DJ; Onions D; Kayser KJ
Biotechnol Bioeng; 2017 Mar; 114(3):576-588. PubMed ID: 27642072
[TBL] [Abstract][Full Text] [Related]
12. The impact of sialylation linkage-type on the pharmacokinetics of recombinant butyrylcholinesterases.
Chung CY; Wang Q; Yang S; Chough S; Seo Y; Cipollo JF; Balthasar JP; Betenbaugh MJ
Biotechnol Bioeng; 2020 Jan; 117(1):157-166. PubMed ID: 31544955
[TBL] [Abstract][Full Text] [Related]
13. Sialylation enhancement of CTLA4-Ig fusion protein in Chinese hamster ovary cells by dexamethasone.
Jing Y; Qian Y; Li ZJ
Biotechnol Bioeng; 2010 Oct; 107(3):488-96. PubMed ID: 20521303
[TBL] [Abstract][Full Text] [Related]
14. Enhanced sialylation of recombinant erythropoietin in genetically engineered Chinese-hamster ovary cells.
Jeong YT; Choi O; Son YD; Park SY; Kim JH
Biotechnol Appl Biochem; 2009 Apr; 52(Pt 4):283-91. PubMed ID: 18590515
[TBL] [Abstract][Full Text] [Related]
15. Enhanced sialylation of a human chimeric IgG1 variant produced in human and rodent cell lines.
Mimura Y; Kelly RM; Unwin L; Albrecht S; Jefferis R; Goodall M; Mizukami Y; Mimura-Kimura Y; Matsumoto T; Ueoka H; Rudd PM
J Immunol Methods; 2016 Jan; 428():30-6. PubMed ID: 26627984
[TBL] [Abstract][Full Text] [Related]
16. Enhanced sialylation of recombinant erythropoietin in CHO cells by human glycosyltransferase expression.
Jeong YT; Choi O; Lim HR; Son YD; Kim HJ; Kim JH
J Microbiol Biotechnol; 2008 Dec; 18(12):1945-52. PubMed ID: 19131698
[TBL] [Abstract][Full Text] [Related]
17. Engineering a bacterial sialyltransferase for di-sialylation of a therapeutic antibody.
Wang M; Wang Y; Liu K; Dou X; Liu Z; Zhang L; Ye XS
Org Biomol Chem; 2020 Apr; 18(15):2886-2892. PubMed ID: 32236230
[TBL] [Abstract][Full Text] [Related]
18. Glycoengineering of therapeutic glycoproteins: in vitro galactosylation and sialylation of glycoproteins with terminal N-acetylglucosamine and galactose residues.
Raju TS; Briggs JB; Chamow SM; Winkler ME; Jones AJ
Biochemistry; 2001 Jul; 40(30):8868-76. PubMed ID: 11467948
[TBL] [Abstract][Full Text] [Related]
19. Engineering host cell lines to reduce terminal sialylation of secreted antibodies.
Naso MF; Tam SH; Scallon BJ; Raju TS
MAbs; 2010; 2(5):519-27. PubMed ID: 20716959
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of sialylation on humanized IgG-like bispecific antibody by overexpression of α2,6-sialyltransferase derived from Chinese hamster ovary cells.
Onitsuka M; Kim WD; Ozaki H; Kawaguchi A; Honda K; Kajiura H; Fujiyama K; Asano R; Kumagai I; Ohtake H; Omasa T
Appl Microbiol Biotechnol; 2012 Apr; 94(1):69-80. PubMed ID: 22205442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
